Literature DB >> 5548486

The assay of a plasma component necessary for the generation of a plasminogen activator in the presence of Hageman factor (Hageman factor co-factor).

D Ogston, N B Bennett, C M Ogston, O D Ratnoff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5548486     DOI: 10.1111/j.1365-2141.1971.tb07029.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.

Authors:  A S Weiss; J I Gallin; A P Kaplan
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

2.  Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.

Authors:  H L Meier; J V Pierce; R W Colman; A P Kaplan
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  Activation of factor XII-dependent pathways in human plasma by hematin and protoporphyrin.

Authors:  C G Becker; M Wagner; A P Kaplan; M Silverberg; R W Grady; H Liem; U Muller-Eberhard
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

4.  Chemotaxis for polymorphonuclear leucocytes induced by soluble antigen- antibody complexes.

Authors:  J Leung-Tack; J Maillard; G A Voisin
Journal:  Immunology       Date:  1977-12       Impact factor: 7.397

5.  Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin.

Authors:  H Saito; O D Ratnoff; J S Marshall; J Pensky
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

6.  Activation of factor XII by tobacco glycoprotein.

Authors:  C G Becker; T Dubin
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

7.  Induction of acute cholecystitis by activation of factor XII.

Authors:  C G Becker; T Dubin; F Glenn
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.